Success Metrics

Clinical Success Rate
89.7%

Based on 26 completed trials

Completion Rate
90%(26/29)
Active Trials
3(8%)
Results Posted
27%(7 trials)
Terminated
3(8%)

Phase Distribution

Ph phase_4
6
17%
Ph early_phase_1
2
6%
Ph not_applicable
2
6%
Ph phase_2
4
11%
Ph phase_1
20
56%
Ph phase_3
1
3%

Phase Distribution

22

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution35 total trials
Early Phase 1First-in-human
2(5.7%)
Phase 1Safety & dosage
20(57.1%)
Phase 2Efficacy & side effects
4(11.4%)
Phase 3Large-scale testing
1(2.9%)
Phase 4Post-market surveillance
6(17.1%)
N/ANon-phased studies
2(5.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.9%

26 of 31 finished

Non-Completion Rate

16.1%

5 ended early

Currently Active

3

trials recruiting

Total Trials

36

all time

Status Distribution
Active(3)
Completed(26)
Terminated(5)
Other(2)

Detailed Status

Completed26
Recruiting3
Terminated3
Withdrawn2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
36
Active
3
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (5.7%)
Phase 120 (57.1%)
Phase 24 (11.4%)
Phase 31 (2.9%)
Phase 46 (17.1%)
N/A2 (5.7%)

Trials by Status

withdrawn26%
recruiting38%
terminated38%
completed2672%
unknown26%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT07154147Phase 4

Oral vs IV Sedation for Cataract Surgery in Older Adults

Completed
NCT05006079Phase 2

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

Recruiting
NCT06293638

Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor

Recruiting
NCT06757140Phase 1

Opioid Drug Interaction Study

Recruiting
NCT05602818Phase 1

A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience

Completed
NCT03509285Phase 1

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

Completed
NCT06357104Phase 4

Detoxification From the Lipid Tract

Completed
NCT04802746Phase 1

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Completed
NCT03635437Phase 1

Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Completed
NCT04857307Phase 1

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Completed
NCT00803400Phase 4

Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment

Completed
NCT04782388Phase 1

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Completed
NCT01046162Phase 1

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

Withdrawn
NCT00810316Phase 1

Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population

Completed
NCT00245609Phase 2

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

Completed
NCT04715269Phase 1

Role of Alprazolam in the Management of Acute Coronary Syndrome

Unknown
NCT03286218Phase 1

A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users

Completed
NCT03012334Phase 1

The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants

Completed
NCT00574639Early Phase 1

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2

Completed
NCT03814733Phase 1

Assessment of Effect of Rapastinel on Driving Performance

Completed

Drug Details

Intervention Type
DRUG
Total Trials
36